Back to Search
ALTON SUTTER, MD
MD
Surgery Physician
NPI: 1922493352IndividualAccepts Medicare
Specialties, Licenses & Credentials
Colon & Rectal Surgery Physician
Colon & Rectal Surgery
Code: 208C00000X
2021-01361(NC)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Surgery PhysicianPrimary
Surgery
Code: 208600000X
2021-01361(NC)
CMS Specialties
PrimaryGENERAL SURGERY
Additional
COLORECTAL SURGERY (PROCTOLOGY)
Education
MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Class of 2015
Research & Publications (20)
A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid.
PMID 17209058·Blood·2007
4-observational
[Management of women with bipolar disorders from conception through the postpartum period].
PMID 17572050·Presse Med·2007
6-review
Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells.
PMID 16530734·Biochem Pharmacol·2006
8-other
Antiangiogenic combination tumor therapy blocking alpha(v)-integrins and VEGF-receptor-2 increases therapeutic effects in vivo.
PMID 16477628·Int J Cancer·2006
7-preclinical
Targeting the epidermal growth factor receptor by erlotinib (Tarceva) for the treatment of esophageal cancer.
PMID 16217753·Int J Cancer·2006
8-other
Decreased brain tryptophan availability as a partial determinant of post-partum blues.
PMID 16303256·Psychoneuroendocrinology·2006
4-observational
Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer.
PMID 17007015·World J Gastroenterol·2006
8-other
Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.
PMID 16937526·World J Gastroenterol·2006
8-other
Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics.
PMID 16023762·J Hepatol·2005
8-other
Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor.
PMID 16083991·J Hepatol·2005
8-other
Mechanisms of mitochondrial apoptosis induced by peripheral benzodiazepine receptor ligands in human colorectal cancer cells.
PMID 15907803·Biochem Biophys Res Commun·2005
8-other
Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer.
PMID 15007244·Onkologie·2004
8-other
The electronification of the radiation oncology treatment cycle: the promises and pitfalls of a digital department.
PMID 17411579·J Am Coll Radiol·2004
8-other
Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.
PMID 15582135·J Hepatol·2004
8-other
Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1.
PMID 15519653·J Hepatol·2004
8-other
Cell cycle-related signaling pathways modulated by peripheral benzodiazepine receptor ligands in colorectal cancer cells.
PMID 15474510·Biochem Biophys Res Commun·2004
8-other
A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine.
PMID 15154969·BMC Cancer·2004
8-other
Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase.
PMID 15081869·Biochem Pharmacol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- MEDICAL CENTER BLVD
WINSTON SALEM, NC 27157 - Phone
- (336) 716-2255
Quick Facts
- NPI
- 1922493352
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile